This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noordzij, M. A. Articles by van Steenbrugge, G. J. Search for Related Content PubMed PubMed Citation Articles by Noordzij, M. A. Articles by van Steenbrugge, G. J.

American Journal of Pathology, Vol 149, 859-871, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Neuroendocrine differentiation in human prostatic tumor models

MA Noordzij, WM van Weerden, CM de Ridder, TH van der Kwast, FH Schroder and GJ van Steenbrugge
Department of Urology, Erasmus University, Rotterdam, The Netherlands.

Neuroendocrine (NE) cells can be identified in benign and malignant prostatic epithelia. Factors regulating their presence and their functions are poorly understood, mainly due to a lack of suitable experimental models. Fifteen in vitro and in vivo prostatic cancer tumor models, including a number of newly established in vivo models, were studied immunohistochemically for the presence of NE cells under different hormonal conditions. None of the in vitro models (PC-3, DU 145, LNCaP, and TSU) contained NE cells. Five of the seven xenograft models established at this laboratory contained NE cells. In three of these, NE cells were found only in the initial mouse passages. In the other two (PC-295 and PC-310), the NE phenotype was stable. NE features were confirmed by transmission electron microscopy and by Western analysis of chromogranin A expression. Immunohistochemical double- labeling experiments confirmed that NE cells in prostate cancer are post-mitotic (no Ki-67 expression) and do not express the androgen receptor. In the PC-295 and PC-310 models, short-term androgen withdrawal resulted in a rapidly increased number of NE cells. A time course experiment with PC-295-bearing mice strongly suggests that this increase occurred by induction of NE differentiation rather than by rapid proliferation and subsequent differentiation or selective persistence. In conclusion, these models are suitable to resolve fundamental questions with regard to the presence and functions of NE cells in human prostate cancer.

This article has been cited by other articles:

				S. Chigurupati, T. Kulkarni, S. Thomas, and G. Shah Calcitonin Stimulates Multiple Stages of Angiogenesis by Directly Acting on Endothelial Cells Cancer Res., September 15, 2005; 65(18): 8519 - 8529. [Abstract] [Full Text] [PDF]

				L. D. True, K. Buhler, J. Quinn, E. Williams, P. S. Nelson, N. Clegg, J. A. Macoska, T. Norwood, A. Liu, W. Ellis, et al. A Neuroendocrine/Small Cell Prostate Carcinoma Xenograft--LuCaP 49 Am. J. Pathol., August 1, 2002; 161(2): 705 - 715. [Abstract] [Full Text] [PDF]

				J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schröder, and G. J. van Steenbrugge Androgen Deprivation of the Prohormone Convertase-310 Human Prostate Cancer Model System Induces Neuroendocrine Differentiation Cancer Res., February 1, 2000; 60(3): 741 - 748. [Abstract] [Full Text]

				J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schroder, and G. J. van Steenbrugge Kinetics of Neuroendocrine Differentiation in an Androgen-Dependent Human Prostate Xenograft Model Am. J. Pathol., February 1, 1999; 154(2): 543 - 551. [Abstract] [Full Text] [PDF]